[Expectations for newly developed antitubercular agents--antitubercular activity of 27753RP].
D000818:Animals; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005260:Female; D006168:Guinea Pigs; D051379:Mice; D010455:Peptides / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D010455:Peptides; C028747:27753R.P.